rs2302615
|
ODC1;SNORA80B;ODC1-DT
|
Colorectal Carcinoma
|
|
0.020 |
GeneticVariation |
BEFREE |
Meta-analysis showed association between SNPs rs6983267, rs11694911 and rs2302615 with CRC risk reduction (All P<0.05).
|
29425227 |
2018 |
rs2302615
|
ODC1;SNORA80B;ODC1-DT
|
Colorectal Carcinoma
|
|
0.020 |
GeneticVariation |
BEFREE |
The primary outcome was colorectal cancer-specific survival dependent on ODC1 (rs2302615) genotype (GG versus GA/AA).
|
19789310 |
2009 |
rs2302615
|
ODC1;SNORA80B;ODC1-DT
|
Malignant tumor of colon
|
|
0.010 |
GeneticVariation |
BEFREE |
Site-specific analysis showed association between SNPs rs1799853 and rs2302615 with reduced colon cancer risk only (P = 0.01 and P = 0.004, respectively), however neither reached significance threshold following multiple test correction.
|
29425227 |
2018 |
rs2302615
|
ODC1;SNORA80B;ODC1-DT
|
Colon Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Site-specific analysis showed association between SNPs rs1799853 and rs2302615 with reduced colon cancer risk only (P = 0.01 and P = 0.004, respectively), however neither reached significance threshold following multiple test correction.
|
29425227 |
2018 |
rs2302616
|
ODC1;SNORA80B;ODC1-DT
|
Central neuroblastoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Children with the minor T allele at rs2302616 of the ODC gene with relapsed or refractory NB had higher levels of urinary polyamine markers and responded better to therapy containing DFMO, compared to those with the major G allele at this locus.
|
26018967 |
2015 |
rs2302616
|
ODC1;SNORA80B;ODC1-DT
|
Neuroblastoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Children with the minor T allele at rs2302616 of the ODC gene with relapsed or refractory NB had higher levels of urinary polyamine markers and responded better to therapy containing DFMO, compared to those with the major G allele at this locus.
|
26018967 |
2015 |
rs2302616
|
ODC1;SNORA80B;ODC1-DT
|
Childhood Neuroblastoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Children with the minor T allele at rs2302616 of the ODC gene with relapsed or refractory NB had higher levels of urinary polyamine markers and responded better to therapy containing DFMO, compared to those with the major G allele at this locus.
|
26018967 |
2015 |
rs2302615
|
ODC1;SNORA80B;ODC1-DT
|
Adenoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Previous studies suggest that a single-nucleotide polymorphism (SNP) in the promoter of the ODC gene (rs2302615) may be associated with adenoma risk and/or response to aspirin chemoprevention.
|
21930798 |
2011 |
rs2302615
|
ODC1;SNORA80B;ODC1-DT
|
Malignant neoplasm of colon and/or rectum
|
|
0.010 |
GeneticVariation |
BEFREE |
The primary outcome was colorectal cancer-specific survival dependent on ODC1 (rs2302615) genotype (GG versus GA/AA).
|
19789310 |
2009 |
rs2302615
|
ODC1;SNORA80B;ODC1-DT
|
Breast Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
This study investigated whether the ODC +316 G > A polymorphism (rs2302615) was associated with the risk of developing breast cancer.
|
19225907 |
2009 |
rs2302615
|
ODC1;SNORA80B;ODC1-DT
|
Malignant neoplasm of breast
|
|
0.010 |
GeneticVariation |
BEFREE |
This study investigated whether the ODC +316 G > A polymorphism (rs2302615) was associated with the risk of developing breast cancer.
|
19225907 |
2009 |